Ru, Qinhua C. External Entity

Publications

Sort by

Selected publications

  • Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.  Journal of clinical oncology : official journal of the American Society of Clinical Oncology2012 Academic Article GET IT
    Times cited: 339

Other